Ozkaynak, M Fevzi <br/><br/>
A pilot study of addition of amifostine to melphalan, carboplatin, etoposide, and cyclophosphamide with autologous hematopoietic stem cell transplantation in pediatric solid tumors-A pediatric blood and marrow transplant consortium study.  [electronic resource] 

 -  Journal of pediatric hematology/oncology  Mar 2008 
 - 204-9 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase I; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1077-4114 
<br/><br/><label>Standard No.: </label>10.1097/MPH.0b013e318162bd0c  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Amifostine--administration & dosage<br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Bone Marrow Transplantation<br/>Bone Neoplasms--diagnosis<br/>Carboplatin--administration & dosage<br/>Central Nervous System Neoplasms--diagnosis<br/>Child<br/>Child, Preschool<br/>Combined Modality Therapy<br/>Cyclophosphamide--administration & dosage<br/>Dose-Response Relationship, Drug<br/>Drug Administration Schedule<br/>Drug-Related Side Effects and Adverse Reactions<br/>Etoposide--administration & dosage<br/>Feasibility Studies<br/>Hematopoietic Stem Cell Transplantation<br/>Hodgkin Disease--diagnosis<br/>Humans<br/>Hypocalcemia--chemically induced<br/>Kidney Neoplasms--diagnosis<br/>Melphalan--administration & dosage<br/>Neoplasms--diagnosis<br/>Neuroblastoma--diagnosis<br/>Pilot Projects<br/>Recurrence<br/>Risk Factors<br/>Sarcoma--diagnosis<br/>Transplantation, Autologous<br/>Transplantation, Homologous<br/>Treatment Outcome<br/>Wilms Tumor--diagnosis